<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37627315</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>16</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Mesenchymal Stem Cell-Derived Extracellular Vesicles: An Emerging Diagnostic and Therapeutic Biomolecules for Neurodegenerative Disabilities.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1250</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom13081250</ELocationID><Abstract><AbstractText>Mesenchymal stem cells (MSCs) are a type of versatile adult stem cells present in various organs. These cells give rise to extracellular vesicles (EVs) containing a diverse array of biologically active elements, making them a promising approach for therapeutics and diagnostics. This article examines the potential therapeutic applications of MSC-derived EVs in addressing neurodegenerative disorders such as Alzheimer's disease (AD), multiple sclerosis (MS), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). Furthermore, the present state-of-the-art for MSC-EV-based therapy in AD, HD, PD, ALS, and MS is discussed. Significant progress has been made in understanding the etiology and potential treatments for a range of neurodegenerative diseases (NDs) over the last few decades. The contents of EVs are carried across cells for intercellular contact, which often results in the control of the recipient cell's homeostasis. Since EVs represent the therapeutically beneficial cargo of parent cells and are devoid of many ethical problems connected with cell-based treatments, they offer a viable cell-free therapy alternative for tissue regeneration and repair. Developing innovative EV-dependent medicines has proven difficult due to the lack of standardized procedures in EV extraction processes as well as their pharmacological characteristics and mechanisms of action. However, recent biotechnology and engineering research has greatly enhanced the content and applicability of MSC-EVs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kandeel</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3668-5147</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh 33516, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morsy</LastName><ForeName>Mohamed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine, Minia University, El-Minia 61511, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkhodair</LastName><ForeName>Khalid M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Anatomy, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhojaily</LastName><ForeName>Sameer</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059630" MajorTopicYN="Y">Mesenchymal Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053687" MajorTopicYN="Y">Adult Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="Y">Huntington Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MSCs-based therapy</Keyword><Keyword MajorTopicYN="N">extracellular vesicles</Keyword><Keyword MajorTopicYN="N">mesenchymal cell</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>7</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37627315</ArticleId><ArticleId IdType="pmc">PMC10452295</ArticleId><ArticleId IdType="doi">10.3390/biom13081250</ArticleId><ArticleId IdType="pii">biom13081250</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ding D.C., Shyu W.C., Lin S.Z. Mesenchymal stem cells. Cell Transplant. 2011;20:5&#x2013;14. doi: 10.3727/096368910X.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368910X</ArticleId><ArticleId IdType="pubmed">21396235</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.-J., Kim N., Cho S.-G. The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. Exp. Mol. Med. 2013;45:e2. doi: 10.1038/emm.2013.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2013.2</ArticleId><ArticleId IdType="pmc">PMC3584660</ArticleId><ArticleId IdType="pubmed">23306700</ArticleId></ArticleIdList></Reference><Reference><Citation>Appaix F., Nissou M.F., van der Sanden B., Dreyfus M., Berger F., Issartel J.P., Wion D. Brain mesenchymal stem cells: The other stem cells of the brain? World J. Stem Cells. 2014;6:134&#x2013;143. doi: 10.4252/wjsc.v6.i2.134.</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v6.i2.134</ArticleId><ArticleId IdType="pmc">PMC3999771</ArticleId><ArticleId IdType="pubmed">24772240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaneialvar H., Soltani L., Rahmani H.R., Lotfi A.S., Soleimani M. Characterization and Classification of Mesenchymal Stem Cells in Several Species Using Surface Markers for Cell Therapy Purposes. Indian J. Clin. Biochem. IJCB. 2018;33:46&#x2013;52. doi: 10.1007/s12291-017-0641-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12291-017-0641-x</ArticleId><ArticleId IdType="pmc">PMC5766460</ArticleId><ArticleId IdType="pubmed">29371769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Qu X., Zhao R.C. Clinical applications of mesenchymal stem cells. J. Hematol. Oncol. 2012;5:19. doi: 10.1186/1756-8722-5-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-8722-5-19</ArticleId><ArticleId IdType="pmc">PMC3416655</ArticleId><ArticleId IdType="pubmed">22546280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.-H., Tseng W.-C., Yang C.-Y., Tarng D.-C. The anti-inflammatory, anti-oxidative, and anti-apoptotic benefits of stem cells in acute ischemic kidney injury. Int. J. Mol. Sci. 2019;20:3529. doi: 10.3390/ijms20143529.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20143529</ArticleId><ArticleId IdType="pmc">PMC6678402</ArticleId><ArticleId IdType="pubmed">31330934</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell C.R., Djonov V., Volarevic V. The cross-talk between mesenchymal stem cells and immune cells in tissue repair and regeneration. Int. J. Mol. Sci. 2021;22:2472. doi: 10.3390/ijms22052472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052472</ArticleId><ArticleId IdType="pmc">PMC7957490</ArticleId><ArticleId IdType="pubmed">33804369</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary J.K., Saini D., Chaudhary P.K., Maurya A., Verma G.K., Gupta A.K., Roshan R., Vats T.K., Garg N., Yadav D. Exploring the immunomodulatory aspect of mesenchymal stem cells for treatment of severe coronavirus disease 19. Cells. 2022;11:2175. doi: 10.3390/cells11142175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11142175</ArticleId><ArticleId IdType="pmc">PMC9322532</ArticleId><ArticleId IdType="pubmed">35883618</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L., Xu W., Li T., Chen J., Shao A., Yan F., Chen G. Stem cell therapy: A promising therapeutic method for intracerebral hemorrhage. Cell Transplant. 2018;27:1809&#x2013;1824. doi: 10.1177/0963689718773363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689718773363</ArticleId><ArticleId IdType="pmc">PMC6300771</ArticleId><ArticleId IdType="pubmed">29871521</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveri R.S., Bello S., Biering-S&#xf8;rensen F. Mesenchymal stem cells improve locomotor recovery in traumatic spinal cord injury: Systematic review with meta-analyses of rat models. Neurobiol. Dis. 2014;62:338&#x2013;353. doi: 10.1016/j.nbd.2013.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.10.014</ArticleId><ArticleId IdType="pubmed">24148857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer H.R., Tuan R.S. Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies. Stem Cell Res. Ther. 2016;7:131. doi: 10.1186/s13287-016-0394-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-016-0394-0</ArticleId><ArticleId IdType="pmc">PMC5016979</ArticleId><ArticleId IdType="pubmed">27612948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahmasebi F., Barati S. Effects of mesenchymal stem cell transplantation on spinal cord injury patients. Cell Tissue Res. 2022;389:373&#x2013;384. doi: 10.1007/s00441-022-03648-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-022-03648-3</ArticleId><ArticleId IdType="pubmed">35697943</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C., Witwer K.W., Aikawa E., Alcaraz M.J., Anderson J.D., Andriantsitohaina R., Antoniou A., Arab T., Archer F., Atkin-Smith G.K. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 2018;7:1535750. doi: 10.1080/20013078.2018.1535750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2018.1535750</ArticleId><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>He X., Zhang C., Amirsaadat S., Jalil A.T., Kadhim M.M., Abasi M., Pilehvar Y. Curcumin-Loaded Mesenchymal Stem Cell&#x2013;Derived Exosomes Efficiently Attenuate Proliferation and Inflammatory Response in Rheumatoid Arthritis Fibroblast-Like Synoviocytes. Appl. Biochem. Biotechnol. 2023;195:51&#x2013;67. doi: 10.1007/s12010-022-04090-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12010-022-04090-5</ArticleId><ArticleId IdType="pubmed">35932371</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai R.C., Arslan F., Lee M.M., Sze N.S.K., Choo A., Chen T.S., Salto-Tellez M., Timmers L., Lee C.N., El Oakley R.M. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010;4:214&#x2013;222. doi: 10.1016/j.scr.2009.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2009.12.003</ArticleId><ArticleId IdType="pubmed">20138817</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang X., Xiang X., Grizzle W., Sun D., Zhang S., Axtell R.C., Ju S., Mu J., Zhang L., Steinman L. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 2011;19:1769&#x2013;1779. doi: 10.1038/mt.2011.164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2011.164</ArticleId><ArticleId IdType="pmc">PMC3188748</ArticleId><ArticleId IdType="pubmed">21915101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wade D.T. Epidemiology of disabling neurological disease: How and why does disability occur? J. Neurol. Neurosurg. Psychiatry. 1997;63:S11&#x2013;S18. doi: 10.1136/jnnp.63.2008.11S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.63.2008.11S</ArticleId><ArticleId IdType="pmc">PMC2169883</ArticleId><ArticleId IdType="pubmed">9408124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy-Malone L. Central and Peripheral Nervous System Disorders. Adv. Pract. Nurs. Care Older Adults. 2018;328</Citation></Reference><Reference><Citation>Lilamand M., Hourregue C., Paquet C. Interest of biological biomarkers in the diagnostic approach of neurocognitive disorders in the elderly. Rev. Neurol. 2020;176:677&#x2013;683. doi: 10.1016/j.neurol.2019.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.12.006</ArticleId><ArticleId IdType="pubmed">32169325</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson A.G., Gray E., Heman-Ackah S.M., M&#xe4;ger I., Talbot K., El Andaloussi S., Wood M.J., Turner M.R. Extracellular vesicles in neurodegenerative disease&#x2014;Pathogenesis to biomarkers. Nat. Rev. Neurol. 2016;12:346&#x2013;357. doi: 10.1038/nrneurol.2016.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.68</ArticleId><ArticleId IdType="pubmed">27174238</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S.M. Neuropsychology of multiple sclerosis. Curr. Opin. Neurol. 1995;8:216&#x2013;220. doi: 10.1097/00019052-199506000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00019052-199506000-00010</ArticleId><ArticleId IdType="pubmed">7551121</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R., Marsden C. How common is dementia in Parkinson&#x2019;s disease? Lancet. 1984;324:1262&#x2013;1265. doi: 10.1016/S0140-6736(84)92807-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(84)92807-1</ArticleId><ArticleId IdType="pubmed">6150288</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaubert F., Chainay H. Decision-Making Competence in Patients with Alzheimer&#x2019;s Disease: A Review of the Literature. Neuropsychol. Rev. 2021;31:267&#x2013;287. doi: 10.1007/s11065-020-09472-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-020-09472-2</ArticleId><ArticleId IdType="pubmed">33576942</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D., Strasser A., Liddell J.R. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 2021;28:2029&#x2013;2044. doi: 10.1038/s41418-021-00814-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00814-y</ArticleId><ArticleId IdType="pmc">PMC8257776</ArticleId><ArticleId IdType="pubmed">34099897</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson D.M., Cookson M.R., Van Den Bosch L., Zetterberg H., Holtzman D.M., Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186:693&#x2013;714. doi: 10.1016/j.cell.2022.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.12.032</ArticleId><ArticleId IdType="pubmed">36803602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li M., Chen Z., Xu L., Chang M., Wang K., Deng C., Gu Y., Zhou S., Shen Y. Biogenesis and function of extracellular vesicles in pathophysiological processes of skeletal muscle atrophy. Biochem. Pharmacol. 2022;198:114954. doi: 10.1016/j.bcp.2022.114954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2022.114954</ArticleId><ArticleId IdType="pubmed">35167807</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil A.A., Rhee W.J. Exosomes: Biogenesis, composition, functions, and their role in pre-metastatic niche formation. Biotechnol. Bioprocess Eng. 2019;24:689&#x2013;701. doi: 10.1007/s12257-019-0170-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12257-019-0170-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassanpour M., Rezaie J., Nouri M., Panahi Y. The role of extracellular vesicles in COVID-19 virus infection. Infect. Genet. Evol. 2020;85:104422. doi: 10.1016/j.meegid.2020.104422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2020.104422</ArticleId><ArticleId IdType="pmc">PMC7293471</ArticleId><ArticleId IdType="pubmed">32544615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricarico C., Clancy J., D&#x2019;Souza-Schorey C. Biology and biogenesis of shed microvesicles. Small GTPases. 2017;8:220&#x2013;232. doi: 10.1080/21541248.2016.1215283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541248.2016.1215283</ArticleId><ArticleId IdType="pmc">PMC5680703</ArticleId><ArticleId IdType="pubmed">27494381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hessvik N.P., Llorente A. Current knowledge on exosome biogenesis and release. Cell. Mol. Life Sci. 2018;75:193&#x2013;208. doi: 10.1007/s00018-017-2595-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2595-9</ArticleId><ArticleId IdType="pmc">PMC5756260</ArticleId><ArticleId IdType="pubmed">28733901</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges F.T., Reis L., Schor N. Extracellular vesicles: Structure, function, and potential clinical uses in renal diseases. Braz. J. Med. Biol. Res. 2013;46:824&#x2013;830. doi: 10.1590/1414-431X20132964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431X20132964</ArticleId><ArticleId IdType="pmc">PMC3854311</ArticleId><ArticleId IdType="pubmed">24141609</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkin-Smith G.K., Tixeira R., Paone S., Mathivanan S., Collins C., Liem M., Goodall K.J., Ravichandran K.S., Hulett M.D., Poon I.K. A novel mechanism of generating extracellular vesicles during apoptosis via a beads-on-a-string membrane structure. Nat. Commun. 2015;6:7439. doi: 10.1038/ncomms8439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8439</ArticleId><ArticleId IdType="pmc">PMC4490561</ArticleId><ArticleId IdType="pubmed">26074490</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakarla R., Hur J., Kim Y.J., Kim J., Chwae Y.-J. Apoptotic cell-derived exosomes: Messages from dying cells. Exp. Mol. Med. 2020;52:1&#x2013;6. doi: 10.1038/s12276-019-0362-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-019-0362-8</ArticleId><ArticleId IdType="pmc">PMC7000698</ArticleId><ArticleId IdType="pubmed">31915368</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaie J., Nejati V., Mahmoodi M., Ahmadi M. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system. Biochem. Pharmacol. 2022;203:115167. doi: 10.1016/j.bcp.2022.115167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2022.115167</ArticleId><ArticleId IdType="pubmed">35820499</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikfarjam S., Rezaie J., Zolbanin N.M., Jafari R. Mesenchymal stem cell derived-exosomes: A modern approach in translational medicine. J. Transl. Med. 2020;18:449. doi: 10.1186/s12967-020-02622-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02622-3</ArticleId><ArticleId IdType="pmc">PMC7691969</ArticleId><ArticleId IdType="pubmed">33246476</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedikter B.J., Bouwman F.G., Vajen T., Heinzmann A.C., Grauls G., Mariman E.C., Wouters E.F., Savelkoul P.H., Lopez-Iglesias C., Koenen R.R. Ultrafiltration combined with size exclusion chromatography efficiently isolates extracellular vesicles from cell culture media for compositional and functional studies. Sci. Rep. 2017;7:15297. doi: 10.1038/s41598-017-15717-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-15717-7</ArticleId><ArticleId IdType="pmc">PMC5681555</ArticleId><ArticleId IdType="pubmed">29127410</ArticleId></ArticleIdList></Reference><Reference><Citation>Stranska R., Gysbrechts L., Wouters J., Vermeersch P., Bloch K., Dierickx D., Andrei G., Snoeck R. Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma. J. Transl. Med. 2018;16:1. doi: 10.1186/s12967-017-1374-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1374-6</ArticleId><ArticleId IdType="pmc">PMC5761138</ArticleId><ArticleId IdType="pubmed">29316942</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowen A., Shahjin F., Chand S., Odegaard K.E., Yelamanchili S.V. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications. Front. Cell Dev. Biol. 2020;8:149. doi: 10.3389/fcell.2020.00149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00149</ArticleId><ArticleId IdType="pmc">PMC7080981</ArticleId><ArticleId IdType="pubmed">32226787</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeria C., Kre&#xdf; S., Weber V., Egger D., Kasper C. Heterogeneity of mesenchymal stem cell-derived extracellular vesicles is highly impacted by the tissue/cell source and culture conditions. Cell Biosci. 2022;12:51. doi: 10.1186/s13578-022-00786-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-022-00786-7</ArticleId><ArticleId IdType="pmc">PMC9063275</ArticleId><ArticleId IdType="pubmed">35501833</ArticleId></ArticleIdList></Reference><Reference><Citation>Maumus M., Rozier P., Boulestreau J., Jorgensen C., No&#xeb;l D. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation. Front. Bioeng. Biotechnol. 2020;8:997. doi: 10.3389/fbioe.2020.00997.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2020.00997</ArticleId><ArticleId IdType="pmc">PMC7511661</ArticleId><ArticleId IdType="pubmed">33015001</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton A., Boilard E., Buzas E.I., Cheng L., Falc&#xf3;n-Perez J.M., Gardiner C., Gustafson D., Gualerzi A., Hendrix A., Hoffman A., et al. Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles. J. Extracell. Vesicles. 2019;8:1647027. doi: 10.1080/20013078.2019.1647027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2019.1647027</ArticleId><ArticleId IdType="pmc">PMC6711123</ArticleId><ArticleId IdType="pubmed">31489143</ArticleId></ArticleIdList></Reference><Reference><Citation>Liangsupree T., Multia E., Riekkola M.-L. Modern isolation and separation techniques for extracellular vesicles. J. Chromatogr. A. 2021;1636:461773. doi: 10.1016/j.chroma.2020.461773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chroma.2020.461773</ArticleId><ArticleId IdType="pubmed">33316564</ArticleId></ArticleIdList></Reference><Reference><Citation>Varderidou-Minasian S., Lorenowicz M.J. Mesenchymal stromal/stem cell-derived extracellular vesicles in tissue repair: Challenges and opportunities. Theranostics. 2020;10:5979&#x2013;5997. doi: 10.7150/thno.40122.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.40122</ArticleId><ArticleId IdType="pmc">PMC7254996</ArticleId><ArticleId IdType="pubmed">32483432</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaborowski M.P., Balaj L., Breakefield X.O., Lai C.P. Extracellular vesicles: Composition, biological relevance, and methods of study. Bioscience. 2015;65:783&#x2013;797. doi: 10.1093/biosci/biv084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biosci/biv084</ArticleId><ArticleId IdType="pmc">PMC4776721</ArticleId><ArticleId IdType="pubmed">26955082</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#xe1;&#xf1;ez-M&#xf3; M., Siljander P.R.-M., Andreu Z., Bedina Zavec A., Borr&#xe0;s F.E., Buzas E.I., Buzas K., Casal E., Cappello F., Carvalho J. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles. 2015;4:27066. doi: 10.3402/jev.v4.27066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v4.27066</ArticleId><ArticleId IdType="pmc">PMC4433489</ArticleId><ArticleId IdType="pubmed">25979354</ArticleId></ArticleIdList></Reference><Reference><Citation>Abels E.R., Breakefield X.O. Introduction to extracellular vesicles: Biogenesis, RNA cargo selection, content, release, and uptake. Cell. Mol. Neurobiol. 2016;36:301&#x2013;312. doi: 10.1007/s10571-016-0366-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-016-0366-z</ArticleId><ArticleId IdType="pmc">PMC5546313</ArticleId><ArticleId IdType="pubmed">27053351</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X., Wang B., Feng X., Xu Y., Lu K., Sun M. circRNAs and exosomes: A mysterious frontier for human cancer. Mol. Ther. -Nucleic Acids. 2020;19:384&#x2013;392. doi: 10.1016/j.omtn.2019.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.11.023</ArticleId><ArticleId IdType="pmc">PMC6939016</ArticleId><ArticleId IdType="pubmed">31887549</ArticleId></ArticleIdList></Reference><Reference><Citation>Akers J.C., Ramakrishnan V., Kim R., Skog J., Nakano I., Pingle S., Kalinina J., Hua W., Kesari S., Mao Y. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): A platform for glioblastoma biomarker development. PLoS ONE. 2013;8:e78115. doi: 10.1371/journal.pone.0078115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0078115</ArticleId><ArticleId IdType="pmc">PMC3804457</ArticleId><ArticleId IdType="pubmed">24205116</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisitkun T., Shen R.-F., Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA. 2004;101:13368&#x2013;13373. doi: 10.1073/pnas.0403453101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0403453101</ArticleId><ArticleId IdType="pmc">PMC516573</ArticleId><ArticleId IdType="pubmed">15326289</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornick N.I., Huan J., Doron B., Goloviznina N.A., Lapidus J., Chang B.H., Kurre P. Serum exosome microRNA as a minimally-invasive early biomarker of AML. Sci. Rep. 2015;5:11295. doi: 10.1038/srep11295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11295</ArticleId><ArticleId IdType="pmc">PMC4650871</ArticleId><ArticleId IdType="pubmed">26067326</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida Y., Yamamoto H., Morita R., Oikawa R., Matsuo Y., Maehata T., Nosho K., Watanabe Y., Yasuda H., Itoh F. Detection of DNA methylation of gastric juice-derived exosomes in gastric cancer. Integr. Mol. Med. 2014;1:17&#x2013;21.</Citation></Reference><Reference><Citation>Goto T., Fujiya M., Konishi H., Sasajima J., Fujibayashi S., Hayashi A., Utsumi T., Sato H., Iwama T., Ijiri M. An elevated expression of serum exosomal microRNA-191,&#x2212; 21,&#x2212; 451a of pancreatic neoplasm is considered to be efficient diagnostic marker. BMC Cancer. 2018;18:116. doi: 10.1186/s12885-018-4006-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-018-4006-5</ArticleId><ArticleId IdType="pmc">PMC5793347</ArticleId><ArticleId IdType="pubmed">29385987</ArticleId></ArticleIdList></Reference><Reference><Citation>Burtenshaw D., Regan B., Owen K., Collins D., McEneaney D., Megson I.L., Redmond E.M., Cahill P.A. Exosomal Composition, Biogenesis and Profiling Using Point-of-Care Diagnostics&#x2014;Implications for Cardiovascular Disease. Front. Cell Dev. Biol. 2022;10:853451. doi: 10.3389/fcell.2022.853451.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.853451</ArticleId><ArticleId IdType="pmc">PMC9198276</ArticleId><ArticleId IdType="pubmed">35721503</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashouri L., Yousefi H., Aref A.R., Ahadi A.m., Molaei F., Alahari S.K. Exosomes: Composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol. Cancer. 2019;18:75. doi: 10.1186/s12943-019-0991-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-019-0991-5</ArticleId><ArticleId IdType="pmc">PMC6444571</ArticleId><ArticleId IdType="pubmed">30940145</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobrie A., Colombo M., Raposo G., Th&#xe9;ry C. Exosome secretion: Molecular mechanisms and roles in immune responses. Traffic. 2011;12:1659&#x2013;1668. doi: 10.1111/j.1600-0854.2011.01225.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2011.01225.x</ArticleId><ArticleId IdType="pubmed">21645191</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaput N., Th&#xe9;ry C. Exosomes: Immune properties and potential clinical implementations. Semin. Immunopathol. 2011;33:419&#x2013;440. doi: 10.1007/s00281-010-0233-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-010-0233-9</ArticleId><ArticleId IdType="pubmed">21174094</ArticleId></ArticleIdList></Reference><Reference><Citation>Faur&#xe9; J., Lachenal G., Court M., Hirrlinger J., Chatellard-Causse C., Blot B., Grange J., Schoehn G., Goldberg Y., Boyer V. Exosomes are released by cultured cortical neurones. Mol. Cell. Neurosci. 2006;31:642&#x2013;648. doi: 10.1016/j.mcn.2005.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2005.12.003</ArticleId><ArticleId IdType="pubmed">16446100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachenal G., Pernet-Gallay K., Chivet M., Hemming F.J., Belly A., Bodon G., Blot B., Haase G., Goldberg Y., Sadoul R. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol. Cell. Neurosci. 2011;46:409&#x2013;418. doi: 10.1016/j.mcn.2010.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2010.11.004</ArticleId><ArticleId IdType="pubmed">21111824</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprague D.L., Elzey B.D., Crist S.A., Waldschmidt T.J., Jensen R.J., Ratliff T.L. Platelet-mediated modulation of adaptive immunity: Unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood J. Am. Soc. Hematol. 2008;111:5028&#x2013;5036. doi: 10.1182/blood-2007-06-097410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-06-097410</ArticleId><ArticleId IdType="pmc">PMC2384131</ArticleId><ArticleId IdType="pubmed">18198347</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Pol E., B&#xf6;ing A., Gool E., Nieuwland R. Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles. J. Thromb. Haemost. 2016;14:48&#x2013;56. doi: 10.1111/jth.13190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13190</ArticleId><ArticleId IdType="pubmed">26564379</ArticleId></ArticleIdList></Reference><Reference><Citation>Balaj L., Lessard R., Dai L., Cho Y.-J., Pomeroy S.L., Breakefield X.O., Skog J. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat. Commun. 2011;2:180. doi: 10.1038/ncomms1180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1180</ArticleId><ArticleId IdType="pmc">PMC3040683</ArticleId><ArticleId IdType="pubmed">21285958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., Xiao T., Schafer J., Lee M.-L.T., Schmittgen T.D. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE. 2008;3:e3694. doi: 10.1371/journal.pone.0003694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003694</ArticleId><ArticleId IdType="pmc">PMC2577891</ArticleId><ArticleId IdType="pubmed">19002258</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellana D., Zobairi F., Martinez M.C., Panaro M.A., Mitolo V., Freyssinet J.-M., Kunzelmann C. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: A role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res. 2009;69:785&#x2013;793. doi: 10.1158/0008-5472.CAN-08-1946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-08-1946</ArticleId><ArticleId IdType="pubmed">19155311</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng Z., Zhang B., Wu C., Yu F., Han B., Li B., Li L. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J. Hematol. Oncol. 2021;14:136. doi: 10.1186/s13045-021-01141-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-021-01141-y</ArticleId><ArticleId IdType="pmc">PMC8414028</ArticleId><ArticleId IdType="pubmed">34479611</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhondt B., Rousseau Q., De Wever O., Hendrix A. Function of extracellular vesicle-associated miRNAs in metastasis. Cell Tissue Res. 2016;365:621&#x2013;641. doi: 10.1007/s00441-016-2430-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-016-2430-x</ArticleId><ArticleId IdType="pubmed">27289232</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams C., Royo F., Aizpurua-Olaizola O., Pazos R., Boons G.-J., Reichardt N.-C., Falcon-Perez J.M. Glycosylation of extracellular vesicles: Current knowledge, tools and clinical perspectives. J. Extracell. Vesicles. 2018;7:1442985. doi: 10.1080/20013078.2018.1442985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2018.1442985</ArticleId><ArticleId IdType="pmc">PMC5844028</ArticleId><ArticleId IdType="pubmed">29535851</ArticleId></ArticleIdList></Reference><Reference><Citation>Hristov M., Erl W., Linder S., Weber P.C. Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood. 2004;104:2761&#x2013;2766. doi: 10.1182/blood-2003-10-3614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-10-3614</ArticleId><ArticleId IdType="pubmed">15242875</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Lai Y., Hua Z.-C. Apoptosis and apoptotic body: Disease message and therapeutic target potentials. Biosci. Rep. 2019;39:BSR20180992. doi: 10.1042/BSR20180992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20180992</ArticleId><ArticleId IdType="pmc">PMC6340950</ArticleId><ArticleId IdType="pubmed">30530866</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmore S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007;35:495&#x2013;516. doi: 10.1080/01926230701320337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01926230701320337</ArticleId><ArticleId IdType="pmc">PMC2117903</ArticleId><ArticleId IdType="pubmed">17562483</ArticleId></ArticleIdList></Reference><Reference><Citation>Escrevente C., Keller S., Altevogt P., Costa J. Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer. 2011;11:108. doi: 10.1186/1471-2407-11-108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2407-11-108</ArticleId><ArticleId IdType="pmc">PMC3072949</ArticleId><ArticleId IdType="pubmed">21439085</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C., Boussac M., V&#xe9;ron P., Ricciardi-Castagnoli P., Raposo G., Garin J., Amigorena S. Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 2001;166:7309&#x2013;7318. doi: 10.4049/jimmunol.166.12.7309.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.12.7309</ArticleId><ArticleId IdType="pubmed">11390481</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle L.M., Wang M.Z. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8:727. doi: 10.3390/cells8070727.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8070727</ArticleId><ArticleId IdType="pmc">PMC6678302</ArticleId><ArticleId IdType="pubmed">31311206</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianni-Barrera R., Trani M., Fontanellaz C., Heberer M., Djonov V., Hlushchuk R., Banfi A. VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting. Angiogenesis. 2013;16:123&#x2013;136. doi: 10.1007/s10456-012-9304-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-012-9304-y</ArticleId><ArticleId IdType="pubmed">22961440</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong M., Yu B., Wang J., Wang Y., Liu M., Paul C., Millard R.W., Xiao D.-S., Ashraf M., Xu M. Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget. 2017;8:45200. doi: 10.18632/oncotarget.16778.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.16778</ArticleId><ArticleId IdType="pmc">PMC5542178</ArticleId><ArticleId IdType="pubmed">28423355</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav L., Puri N., Rastogi V., Satpute P., Sharma V. Tumour angiogenesis and angiogenic inhibitors: A review. J. Clin. Diagn. Res. JCDR. 2015;9:XE01. doi: 10.7860/JCDR/2015/12016.6135.</Citation><ArticleIdList><ArticleId IdType="doi">10.7860/JCDR/2015/12016.6135</ArticleId><ArticleId IdType="pmc">PMC4525594</ArticleId><ArticleId IdType="pubmed">26266204</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell C.R., Fellabaum C., Jovicic N., Djonov V., Arsenijevic N., Volarevic V. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells. 2019;8:467. doi: 10.3390/cells8050467.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8050467</ArticleId><ArticleId IdType="pmc">PMC6562906</ArticleId><ArticleId IdType="pubmed">31100966</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreras-Planella L., Mongui&#xf3;-Tortajada M., Borr&#xe0;s F.E., Franquesa M. Immunomodulatory effect of MSC on B cells is independent of secreted extracellular vesicles. Front. Immunol. 2019;10:1288. doi: 10.3389/fimmu.2019.01288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01288</ArticleId><ArticleId IdType="pmc">PMC6563675</ArticleId><ArticleId IdType="pubmed">31244839</ArticleId></ArticleIdList></Reference><Reference><Citation>Luther K.M., Haar L., McGuinness M., Wang Y., Lynch IV T.L., Phan A., Song Y., Shen Z., Gardner G., Kuffel G. Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells. J. Mol. Cell. Cardiol. 2018;119:125&#x2013;137. doi: 10.1016/j.yjmcc.2018.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2018.04.012</ArticleId><ArticleId IdType="pubmed">29698635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji W., Jiang W., Li M., Li J., Li Z. miR-21 deficiency contributes to the impaired protective effects of obese rat mesenchymal stem cell-derived exosomes against spinal cord injury. Biochimie. 2019;167:171&#x2013;178. doi: 10.1016/j.biochi.2019.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2019.10.002</ArticleId><ArticleId IdType="pubmed">31605737</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou G., Yang Y., Liu F., Ye B., Chen Z., Zheng M., Liu Y. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. J. Cell. Mol. Med. 2017;21:2963&#x2013;2973. doi: 10.1111/jcmm.13208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13208</ArticleId><ArticleId IdType="pmc">PMC5661245</ArticleId><ArticleId IdType="pubmed">28544786</ArticleId></ArticleIdList></Reference><Reference><Citation>Eirin A., Zhu X.-Y., Puranik A.S., Tang H., McGurren K.A., van Wijnen A.J., Lerman A., Lerman L.O. Mesenchymal stem cell&#x2013;derived extracellular vesicles attenuate kidney inflammation. Kidney Int. 2017;92:114&#x2013;124. doi: 10.1016/j.kint.2016.12.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2016.12.023</ArticleId><ArticleId IdType="pmc">PMC5483390</ArticleId><ArticleId IdType="pubmed">28242034</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaubey S., Thueson S., Ponnalagu D., Alam M.A., Gheorghe C.P., Aghai Z., Singh H., Bhandari V. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6. Stem Cell Res. Ther. 2018;9:173. doi: 10.1186/s13287-018-0903-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-018-0903-4</ArticleId><ArticleId IdType="pmc">PMC6019224</ArticleId><ArticleId IdType="pubmed">29941022</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., Liu J., Zhang F., Wang Y., Qin Y., Zhou Z., Qiu J., Fan Y. CCR2 positive exosome released by mesenchymal stem cells suppresses macrophage functions and alleviates ischemia/reperfusion-induced renal injury. Stem Cells Int. 2016;2016:1240301. doi: 10.1155/2016/1240301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/1240301</ArticleId><ArticleId IdType="pmc">PMC5098097</ArticleId><ArticleId IdType="pubmed">27843457</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis M., Mavin E., Nicholson L., Green K., Dickinson A.M., Wang X.-n. Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function. Front. Immunol. 2018;9:2538. doi: 10.3389/fimmu.2018.02538.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02538</ArticleId><ArticleId IdType="pmc">PMC6237916</ArticleId><ArticleId IdType="pubmed">30473695</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Gu H., Qin D., Yang L., Huang W., Essandoh K., Wang Y., Caldwell C.C., Peng T., Zingarelli B., et al. Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis. Sci. Rep. 2015;5:13721. doi: 10.1038/srep13721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13721</ArticleId><ArticleId IdType="pmc">PMC4562230</ArticleId><ArticleId IdType="pubmed">26348153</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Lu F.-b., Chen D.-z., Wu J.-l., Xu L.-m., Zheng M.-h., Li H., Huang Y., Jin X.-y., Gong Y.-w. BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis. Mol. Immunol. 2018;93:38&#x2013;46. doi: 10.1016/j.molimm.2017.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2017.11.008</ArticleId><ArticleId IdType="pubmed">29145157</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Rufino J.D., Espinosa-Lara N., Osugui L., Sanchez-Guijo F. Targeting the immune system with mesenchymal stromal cell-derived extracellular vesicles: What is the Cargo&#x2019;s mechanism of action? Front. Bioeng. Biotechnol. 2019;7:308. doi: 10.3389/fbioe.2019.00308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2019.00308</ArticleId><ArticleId IdType="pmc">PMC6856662</ArticleId><ArticleId IdType="pubmed">31781552</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandeel M. Oncogenic Viruses-Encoded microRNAs and Their Role in the Progression of Cancer: Emerging Targets for Antiviral and Anticancer Therapies. Pharmaceuticals. 2023;16:485. doi: 10.3390/ph16040485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph16040485</ArticleId><ArticleId IdType="pmc">PMC10146417</ArticleId><ArticleId IdType="pubmed">37111242</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Y., Zhou X., Wang J., Shen H., Wu S., Guo W., Yang Y. MSC derived EV loaded with miRNA-22 inhibits the inflammatory response and nerve function recovery after spinal cord injury in rats. J. Cell. Mol. Med. 2021;25:10268&#x2013;10278. doi: 10.1111/jcmm.16965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16965</ArticleId><ArticleId IdType="pmc">PMC8572783</ArticleId><ArticleId IdType="pubmed">34609045</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y., Huang W., Wani M., Yu X., Ashraf M. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS ONE. 2014;9:e88685. doi: 10.1371/journal.pone.0088685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0088685</ArticleId><ArticleId IdType="pmc">PMC3928277</ArticleId><ArticleId IdType="pubmed">24558412</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong M., Wang M., Xu J., Yu B., Wang Y.-G., Liu M., Ashraf M., Xu M. Nano-sized extracellular vesicles secreted from GATA-4 modified mesenchymal stem cells promote angiogenesis by delivering Let-7 miRNAs. Cells. 2022;11:1573. doi: 10.3390/cells11091573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11091573</ArticleId><ArticleId IdType="pmc">PMC9104414</ArticleId><ArticleId IdType="pubmed">35563879</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Gao J., Gao F., Zhao Y., Deng B., Mu X., Xu L. Extracellular vesicles-encapsulated microRNA-29b-3p from bone marrow-derived mesenchymal stem cells promotes fracture healing via modulation of the PTEN/PI3K/AKT axis. Exp. Cell Res. 2022;412:113026. doi: 10.1016/j.yexcr.2022.113026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2022.113026</ArticleId><ArticleId IdType="pubmed">35026284</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J.-H., Xu Y., Yin X.-M., Lin F.-Y. Exosomes derived from miR-126-modified MSCs promote angiogenesis and neurogenesis and attenuate apoptosis after spinal cord injury in rats. Neuroscience. 2020;424:133&#x2013;145. doi: 10.1016/j.neuroscience.2019.10.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2019.10.043</ArticleId><ArticleId IdType="pubmed">31704348</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei Z., Cen J., Zhang X., Gong C., Sun M., Meng W., Mao G., Wan J., Hu B., He X. MiR-146a-5p delivered by hucMSC extracellular vesicles modulates the inflammatory response to sulfur mustard-induced acute lung injury. Stem Cell Res. Ther. 2023;14:149. doi: 10.1186/s13287-023-03375-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-023-03375-8</ArticleId><ArticleId IdType="pmc">PMC10227795</ArticleId><ArticleId IdType="pubmed">37254188</ArticleId></ArticleIdList></Reference><Reference><Citation>Pers Y.-M., Bony C., Duroux-Richard I., Bernard L., Maumus M., Assou S., Barry F., Jorgensen C., No&#xeb;l D. miR-155 contributes to the immunoregulatory function of human mesenchymal stem cells. Front. Immunol. 2021;12:624024. doi: 10.3389/fimmu.2021.624024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.624024</ArticleId><ArticleId IdType="pmc">PMC8033167</ArticleId><ArticleId IdType="pubmed">33841404</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira J.M.F., Zamproni L.N., Wendt C.H., Rocha de Miranda K., Lindoso R.S., Won Han S. Overexpression of mir-135b and mir-210 in mesenchymal stromal cells for the enrichment of extracellular vesicles with angiogenic factors. PLoS ONE. 2022;17:e0272962. doi: 10.1371/journal.pone.0272962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0272962</ArticleId><ArticleId IdType="pmc">PMC9380919</ArticleId><ArticleId IdType="pubmed">35972944</ArticleId></ArticleIdList></Reference><Reference><Citation>Song B.-W., Lee C.Y., Kim R., Kim W.J., Lee H.W., Lee M.Y., Kim J., Jeong J.-Y., Chang W. Multiplexed targeting of miRNA-210 in stem cell-derived extracellular vesicles promotes selective regeneration in ischemic hearts. Exp. Mol. Med. 2021;53:695&#x2013;708. doi: 10.1038/s12276-021-00584-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00584-0</ArticleId><ArticleId IdType="pmc">PMC8102609</ArticleId><ArticleId IdType="pubmed">33879860</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M., Liao M., Liu R., Zhang Q., Zhang S., He Y., Jin J., Zhang P., Zhou L. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with miR-223 ameliorate myocardial infarction through P53/S100A9 axis. Genomics. 2022;114:110319. doi: 10.1016/j.ygeno.2022.110319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2022.110319</ArticleId><ArticleId IdType="pubmed">35227836</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Gao Z., Wu J., Zheng X., Jing S., Wang W. MSC-derived extracellular vesicles activate mitophagy to alleviate renal ischemia/reperfusion injury via the miR-223-3p/NLRP3 axis. Stem Cells Int. 2022;2022:6852661. doi: 10.1155/2022/6852661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/6852661</ArticleId><ArticleId IdType="pmc">PMC9142309</ArticleId><ArticleId IdType="pubmed">35646124</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei H., Xu Y., Chen Q., Chen H., Zhu X., Li Y. Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis. Cell Death Dis. 2020;11:290. doi: 10.1038/s41419-020-2490-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2490-4</ArticleId><ArticleId IdType="pmc">PMC7184756</ArticleId><ArticleId IdType="pubmed">32341353</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin H., Katakowski M., Wang F., Qian J.-Y., Liu X.S., Ali M.M., Buller B., Zhang Z.G., Chopp M. MicroRNA-17&#x2013;92 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats. Stroke. 2017;48:747&#x2013;753. doi: 10.1161/STROKEAHA.116.015204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.116.015204</ArticleId><ArticleId IdType="pmc">PMC5330787</ArticleId><ArticleId IdType="pubmed">28232590</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Li X., Wu G., Qi P., Zhang Y., Liu Z., Li X., Yu Y., Ye X., Li Y. Umbilical cord mesenchymal stem cell-derived small extracellular vesicles deliver miR-21 to promote corneal epithelial wound healing through PTEN/PI3K/Akt pathway. Stem Cells Int. 2022;2022:1252557. doi: 10.1155/2022/1252557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/1252557</ArticleId><ArticleId IdType="pmc">PMC9303509</ArticleId><ArticleId IdType="pubmed">35873535</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H., Wang D., Li L., Yin H., He G., Zhang Y. Role of microRNA-335 carried by bone marrow mesenchymal stem cells-derived extracellular vesicles in bone fracture recovery. Cell Death Dis. 2021;12:156. doi: 10.1038/s41419-021-03430-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03430-3</ArticleId><ArticleId IdType="pmc">PMC7862274</ArticleId><ArticleId IdType="pubmed">33542183</ArticleId></ArticleIdList></Reference><Reference><Citation>Manu M.S., Hohjoh H., Yamamura T. Extracellular vesicles as pro-and anti-inflammatory mediators, biomarkers and potential therapeutic agents in multiple sclerosis. Aging Dis. 2021;12:1451. doi: 10.14336/AD.2021.0513.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.0513</ArticleId><ArticleId IdType="pmc">PMC8407883</ArticleId><ArticleId IdType="pubmed">34527421</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing L., Hua X., Yuanna D., Rukun Z., Junjun M. Exosomal miR-499a-5p inhibits endometrial cancer growth and metastasis via targeting VAV3. Cancer Manag. Res. 2020;12:13541&#x2013;13552. doi: 10.2147/CMAR.S283747.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CMAR.S283747</ArticleId><ArticleId IdType="pmc">PMC7781017</ArticleId><ArticleId IdType="pubmed">33408524</ArticleId></ArticleIdList></Reference><Reference><Citation>Kossl J., Bohacova P., Hermankova B., Javorkova E., Zajicova A., Holan V. Antiapoptotic Properties of Mesenchymal Stem Cells in a Mouse Model of Corneal Inflammation. Stem Cells Dev. 2021;30:418&#x2013;427. doi: 10.1089/scd.2020.0195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2020.0195</ArticleId><ArticleId IdType="pubmed">33607933</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard O., Jeny F., Uzunhan Y., Dondi E., Terfous R., Label R., Sutton A., Larghero J., Vanneaux V., Nunes H. Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating HIF and ROS hypoxic signaling. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2018;314:L360&#x2013;L371. doi: 10.1152/ajplung.00153.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00153.2017</ArticleId><ArticleId IdType="pubmed">29167125</ArticleId></ArticleIdList></Reference><Reference><Citation>Bari E., Ferrarotti I., Saracino L., Perteghella S., Torre M.L., Corsico A.G. Mesenchymal stromal cell secretome for severe COVID-19 infections: Premises for the therapeutic use. Cells. 2020;9:924. doi: 10.3390/cells9040924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040924</ArticleId><ArticleId IdType="pmc">PMC7226831</ArticleId><ArticleId IdType="pubmed">32283815</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#x171;zes G., Sipos F. Mesenchymal stem cell-derived secretome: A potential therapeutic option for autoimmune and immune-mediated inflammatory diseases. Cells. 2022;11:2300. doi: 10.3390/cells11152300.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11152300</ArticleId><ArticleId IdType="pmc">PMC9367576</ArticleId><ArticleId IdType="pubmed">35892597</ArticleId></ArticleIdList></Reference><Reference><Citation>Shologu N., Scully M., Laffey J.G., O&#x2019;Toole D. Human Mesenchymal Stem Cell Secretome from Bone Marrow or Adipose-Derived Tissue Sources for Treatment of Hypoxia-Induced Pulmonary Epithelial Injury. Int. J. Mol. Sci. 2018;19:2996. doi: 10.3390/ijms19102996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19102996</ArticleId><ArticleId IdType="pmc">PMC6212866</ArticleId><ArticleId IdType="pubmed">30274394</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Gonz&#xe1;lez A., Garc&#xed;a-S&#xe1;nchez D., Dotta M., Rodr&#xed;guez-Rey J.C., P&#xe9;rez-Campo F.M. Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine. World J. Stem Cells. 2020;12:1529&#x2013;1552. doi: 10.4252/wjsc.v12.i12.1529.</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v12.i12.1529</ArticleId><ArticleId IdType="pmc">PMC7789121</ArticleId><ArticleId IdType="pubmed">33505599</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y., Yang J., Fang J., Zhou Y., Candi E., Wang J., Hua D., Shao C., Shi Y. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct. Target. Ther. 2022;7:92. doi: 10.1038/s41392-022-00932-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00932-0</ArticleId><ArticleId IdType="pmc">PMC8935608</ArticleId><ArticleId IdType="pubmed">35314676</ArticleId></ArticleIdList></Reference><Reference><Citation>An S., Anwar K., Ashraf M., Lee H., Jung R., Koganti R., Ghassemi M., Djalilian A.R. Wound-Healing Effects of Mesenchymal Stromal Cell Secretome in the Cornea and the Role of Exosomes. Pharmaceutics. 2023;15:1486. doi: 10.3390/pharmaceutics15051486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics15051486</ArticleId><ArticleId IdType="pmc">PMC10221647</ArticleId><ArticleId IdType="pubmed">37242728</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Li S., Yu Q., Chen T., Liu D. Application of stem cells in regeneration medicine. MedComm. 2023;4:e291. doi: 10.1002/mco2.291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.291</ArticleId><ArticleId IdType="pmc">PMC10276889</ArticleId><ArticleId IdType="pubmed">37337579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan T., Luo M., Wei X. Mesenchymal stem/stromal cells in cancer therapy. J. Hematol. Oncol. 2021;14:195. doi: 10.1186/s13045-021-01208-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-021-01208-w</ArticleId><ArticleId IdType="pmc">PMC8596342</ArticleId><ArticleId IdType="pubmed">34789315</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang S.H.M., D&#x2019;Rozario J., Mendonca S., Bhuvan T., Payne N.L., Zheng D., Hisana A., Wallis G., Barugahare A., Powell D., et al. Mesenchymal stromal cell apoptosis is required for their therapeutic function. Nat. Commun. 2021;12:6495. doi: 10.1038/s41467-021-26834-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26834-3</ArticleId><ArticleId IdType="pmc">PMC8586224</ArticleId><ArticleId IdType="pubmed">34764248</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizoso F.J., Eiro N., Cid S., Schneider J., Perez-Fernandez R. Mesenchymal stem cell secretome: Toward cell-free therapeutic strategies in regenerative medicine. Int. J. Mol. Sci. 2017;18:1852. doi: 10.3390/ijms18091852.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18091852</ArticleId><ArticleId IdType="pmc">PMC5618501</ArticleId><ArticleId IdType="pubmed">28841158</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Poll D., Parekkadan B., Cho C.H., Berthiaume F., Nahmias Y., Tilles A.W., Yarmush M.L. Mesenchymal stem cell&#x2013;derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008;47:1634&#x2013;1643. doi: 10.1002/hep.22236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.22236</ArticleId><ArticleId IdType="pubmed">18395843</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazdic M., Simovic Markovic B., Vucicevic L., Nikolic T., Djonov V., Arsenijevic N., Trajkovic V., Lukic M.L., Volarevic V. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase-and indoleamine 2, 3-dioxygenase-dependent manner. J. Tissue Eng. Regen. Med. 2018;12:e1173&#x2013;e1185. doi: 10.1002/term.2452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/term.2452</ArticleId><ArticleId IdType="pubmed">28488390</ArticleId></ArticleIdList></Reference><Reference><Citation>Xagorari A., Siotou E., Yiangou M., Tsolaki E., Bougiouklis D., Sakkas L., Fassas A., Anagnostopoulos A. Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury. Int. J. Clin. Exp. Pathol. 2013;6:831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3638093</ArticleId><ArticleId IdType="pubmed">23638214</ArticleId></ArticleIdList></Reference><Reference><Citation>Milosavljevic N., Gazdic M., Simovic Markovic B., Arsenijevic A., Nurkovic J., Dolicanin Z., Djonov V., Lukic M.L., Volarevic V. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. Liver Transplant. 2017;23:1040&#x2013;1050. doi: 10.1002/lt.24784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.24784</ArticleId><ArticleId IdType="pubmed">28481005</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabre T., Molina M.F., Soucy G., Goulet J.-P., Willems B., Villeneuve J.-P., Bilodeau M., Shoukry N.H. Type 3 cytokines IL-17A and IL-22 drive TGF-&#x3b2;&#x2013;dependent liver fibrosis. Sci. Immunol. 2018;3:eaar7754. doi: 10.1126/sciimmunol.aar7754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aar7754</ArticleId><ArticleId IdType="pubmed">30366940</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H., B&#xfc;rger K., Teipel S.J., Bokde A.L., Zetterberg H., Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. J. Alzheimer&#x2019;s Assoc. 2008;4:38&#x2013;48. doi: 10.1016/j.jalz.2007.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2007.08.006</ArticleId><ArticleId IdType="pubmed">18631949</ArticleId></ArticleIdList></Reference><Reference><Citation>Guix F.X., Corbett G.T., Cha D.J., Mustapic M., Liu W., Mengel D., Chen Z., Aikawa E., Young-Pearse T., Kapogiannis D. Detection of aggregation-competent tau in neuron-derived extracellular vesicles. Int. J. Mol. Sci. 2018;19:663. doi: 10.3390/ijms19030663.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19030663</ArticleId><ArticleId IdType="pmc">PMC5877524</ArticleId><ArticleId IdType="pubmed">29495441</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell B.J., Malvankar M.M., Tallon C., Slusher B.S. Sowing the seeds of discovery: Tau-propagation models of Alzheimer&#x2019;s disease. ACS Chem. Neurosci. 2020;11:3499&#x2013;3509. doi: 10.1021/acschemneuro.0c00531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00531</ArticleId><ArticleId IdType="pmc">PMC7992042</ArticleId><ArticleId IdType="pubmed">33050700</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha D.J., Mengel D., Mustapic M., Liu W., Selkoe D.J., Kapogiannis D., Galasko D., Rissman R.A., Bennett D.A., Walsh D.M. miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer&#x2019;s Patients. Front. Neurosci. 2019;13:1208. doi: 10.3389/fnins.2019.01208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01208</ArticleId><ArticleId IdType="pmc">PMC6902042</ArticleId><ArticleId IdType="pubmed">31849573</ArticleId></ArticleIdList></Reference><Reference><Citation>Molinuevo J.L., Ayton S., Batrla R., Bednar M.M., Bittner T., Cummings J., Fagan A.M., Hampel H., Mielke M.M., Mikulskis A. Current state of Alzheimer&#x2019;s fluid biomarkers. Acta Neuropathol. 2018;136:821&#x2013;853. doi: 10.1007/s00401-018-1932-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1932-x</ArticleId><ArticleId IdType="pmc">PMC6280827</ArticleId><ArticleId IdType="pubmed">30488277</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelopoulou E., Paudel Y.N., Piperi C. miR-124 and Parkinson&#x2019;s disease: A biomarker with therapeutic potential. Pharmacol. Res. 2019;150:104515. doi: 10.1016/j.phrs.2019.104515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.104515</ArticleId><ArticleId IdType="pubmed">31707035</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossi I., Radeghieri A., Paolini L., Porrini V., Pilotto A., Padovani A., Marengoni A., Barbon A., Bellucci A., Pizzi M. MicroRNA-34a-5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson&#x2019;s disease: An exploratory study. Int. J. Mol. Med. 2021;47:533&#x2013;546. doi: 10.3892/ijmm.2020.4806.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2020.4806</ArticleId><ArticleId IdType="pmc">PMC7797475</ArticleId><ArticleId IdType="pubmed">33416118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Z., Shi M., Chung K.A., Quinn J.F., Peskind E.R., Galasko D., Jankovic J., Zabetian C.P., Leverenz J.B., Baird G. DJ-1 and &#x3b1;-synuclein in human cerebrospinal fluid as biomarkers of Parkinson&#x2019;s disease. Brain. 2010;133:713&#x2013;726. doi: 10.1093/brain/awq008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq008</ArticleId><ArticleId IdType="pmc">PMC2842513</ArticleId><ArticleId IdType="pubmed">20157014</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagot F., Davoust N. Is it worth considering circulating microRNAs in multiple sclerosis? Front. Immunol. 2016;7:129. doi: 10.3389/fimmu.2016.00129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00129</ArticleId><ArticleId IdType="pmc">PMC4821089</ArticleId><ArticleId IdType="pubmed">27092141</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi D., Bresolin N., Comi G.P., Corti S. Extracellular vesicles and amyotrophic lateral sclerosis: From misfolded protein vehicles to promising clinical biomarkers. Cell. Mol. Life Sci. CMLS. 2021;78:561&#x2013;572. doi: 10.1007/s00018-020-03619-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03619-3</ArticleId><ArticleId IdType="pmc">PMC7872995</ArticleId><ArticleId IdType="pubmed">32803397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ananbeh H., Novak J., Juhas S., Juhasova J., Klempir J., Doleckova K., Rysankova I., Turnovcova K., Hanus J., Hansikova H. Huntingtin co-isolates with small extracellular vesicles from blood plasma of TgHD and KI-HD pig models of Huntington&#x2019;s disease and human blood plasma. Int. J. Mol. Sci. 2022;23:5598. doi: 10.3390/ijms23105598.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23105598</ArticleId><ArticleId IdType="pmc">PMC9147436</ArticleId><ArticleId IdType="pubmed">35628406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudar K.M., Nagaraj P., Nithisaa S., Aishwarya R., Aakash M., Lakshmi S.I. Alzheimer&#x2019;s Disease Analysis using Explainable Artificial Intelligence (XAI); Proceedings of the 2022 International Conference on Sustainable Computing and Data Communication Systems (ICSCDS); Erode, India. 7&#x2013;9 April 2022; pp. 419&#x2013;423.</Citation></Reference><Reference><Citation>Khan S., Barve K.H., Kumar M.S. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer&#x2019;s disease. Curr. Neuropharmacol. 2020;18:1106&#x2013;1125. doi: 10.2174/1570159X18666200528142429.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X18666200528142429</ArticleId><ArticleId IdType="pmc">PMC7709159</ArticleId><ArticleId IdType="pubmed">32484110</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B., Karran E. The cellular phase of Alzheimer&#x2019;s disease. Cell. 2016;164:603&#x2013;615. doi: 10.1016/j.cell.2015.12.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.056</ArticleId><ArticleId IdType="pubmed">26871627</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestro S., Valeri A., Mazzon E. Aducanumab and its effects on tau pathology: Is this the turning point of amyloid hypothesis? Int. J. Mol. Sci. 2022;23:2011. doi: 10.3390/ijms23042011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23042011</ArticleId><ArticleId IdType="pmc">PMC8880389</ArticleId><ArticleId IdType="pubmed">35216126</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X., Wang X., Geng M. Alzheimer&#x2019;s disease hypothesis and related therapies. Transl. Neurodegener. 2018;7:2. doi: 10.1186/s40035-018-0107-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-018-0107-y</ArticleId><ArticleId IdType="pmc">PMC5789526</ArticleId><ArticleId IdType="pubmed">29423193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandeel M., Morsy M.A., El-lateef A., Hany M., Marzok M., El-Beltagi H., Alkhodair K., Albokhadaim I., Venugopala K.N. Cognitive-and Memory-Enhancing Effects of Augmentin in Alzheimer&#x2019;s Rats Through Regulation of Gene Expression and Neuronal Cell Apoptosis. Front. Pharmacol. 2023;14:635. doi: 10.3389/fphar.2023.1154607.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1154607</ArticleId><ArticleId IdType="pmc">PMC10033694</ArticleId><ArticleId IdType="pubmed">36969860</ArticleId></ArticleIdList></Reference><Reference><Citation>Birks J.S., Harvey R.J. Donepezil for dementia due to Alzheimer&#x2019;s disease. Cochrane Database Syst. Rev. 2018;2018:CD001190. doi: 10.1002/14651858.CD001190.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001190.pub3</ArticleId><ArticleId IdType="pubmed">12917900</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamlett E.D., Goetzl E.J., Ledreux A., Vasilevko V., Boger H.A., LaRosa A., Clark D., Carroll S.L., Carmona-Iragui M., Fortea J. Neuronal exosomes reveal Alzheimer&#x2019;s disease biomarkers in Down syndrome. Alzheimer&#x2019;s Dement. 2017;13:541&#x2013;549. doi: 10.1016/j.jalz.2016.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.08.012</ArticleId><ArticleId IdType="pmc">PMC5812672</ArticleId><ArticleId IdType="pubmed">27755974</ArticleId></ArticleIdList></Reference><Reference><Citation>Pusic K.M., Grinberg Y.Y., Kraig R.P., Pusic A.D. Exosome-Based Therapeutics Against Neurodegenerative Disorders. US20190160097A1. U.S. Patent. 2019 May 30;</Citation></Reference><Reference><Citation>Abner E.L., Elahi F.M., Jicha G.A., Mustapic M., Al-Janabi O., Kramer J.H., Kapogiannis D., Goetzl E.J. Endothelial-derived plasma exosome proteins in Alzheimer&#x2019;s disease angiopathy. FASEB J. 2020;34:5967&#x2013;5974. doi: 10.1096/fj.202000034R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000034R</ArticleId><ArticleId IdType="pmc">PMC7233139</ArticleId><ArticleId IdType="pubmed">32157747</ArticleId></ArticleIdList></Reference><Reference><Citation>Saman S., Kim W., Raya M., Visnick Y., Miro S., Saman S., Jackson B., McKee A.C., Alvarez V.E., Lee N.C. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J. Biol. Chem. 2012;287:3842&#x2013;3849. doi: 10.1074/jbc.M111.277061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.277061</ArticleId><ArticleId IdType="pmc">PMC3281682</ArticleId><ArticleId IdType="pubmed">22057275</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewczuk P., Kornhuber J., Vanmechelen E., Peters O., Heuser I., Maier W., Jessen F., B&#xfc;rger K., Hampel H., Fr&#xf6;lich L. Amyloid &#x3b2; peptides in plasma in early diagnosis of Alzheimer&#x2019;s disease: A multicenter study with multiplexing. Exp. Neurol. 2010;223:366&#x2013;370. doi: 10.1016/j.expneurol.2009.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.07.024</ArticleId><ArticleId IdType="pubmed">19664622</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiandaca M.S., Kapogiannis D., Mapstone M., Boxer A., Eitan E., Schwartz J.B., Abner E.L., Petersen R.C., Federoff H.J., Miller B.L. Identification of preclinical Alzheimer&#x2019;s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimer&#x2019;s Dement. 2015;11:600&#x2013;607.e601. doi: 10.1016/j.jalz.2014.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.06.008</ArticleId><ArticleId IdType="pmc">PMC4329112</ArticleId><ArticleId IdType="pubmed">25130657</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark C.M., Xie S., Chittams J., Ewbank D., Peskind E., Galasko D., Morris J.C., McKeel D.W., Farlow M., Weitlauf S.L. Cerebrospinal fluid tau and &#x3b2;-amyloid: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch. Neurol. 2003;60:1696&#x2013;1702. doi: 10.1001/archneur.60.12.1696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.60.12.1696</ArticleId><ArticleId IdType="pubmed">14676043</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J., V&#xe1;zquez-Higuera J.L., Pozueta A., Lage C., Kazimierczak M., Bravo M., Calero M., Gonalez&#xe1;lez A., Rodr&#xed;guez E., Lle&#xf3; A. MicroRNA profile in patients with Alzheimer&#x2019;s disease: Analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples. J. Alzheimer&#x2019;s Dis. 2017;57:483&#x2013;491. doi: 10.3233/JAD-161179.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-161179</ArticleId><ArticleId IdType="pubmed">28269782</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson N., Zetterberg H., Janelidze S., Insel P.S., Andreasson U., Stomrud E., Palmqvist S., Baker D., Hehir C.A.T., Jeromin A. Plasma tau in Alzheimer disease. Neurology. 2016;87:1827&#x2013;1835. doi: 10.1212/WNL.0000000000003246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003246</ArticleId><ArticleId IdType="pmc">PMC5089525</ArticleId><ArticleId IdType="pubmed">27694257</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl E.J., Kapogiannis D., Schwartz J.B., Lobach I.V., Goetzl L., Abner E.L., Jicha G.A., Karydas A.M., Boxer A., Miller B.L. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer&#x2019;s disease. FASEB J. 2016;30:4141&#x2013;4148. doi: 10.1096/fj.201600816R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600816R</ArticleId><ArticleId IdType="pmc">PMC5102122</ArticleId><ArticleId IdType="pubmed">27601437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Cesca F., Loers G., Schweizer M., Buck F., Benfenati F., Schachner M., Kleene R. Synapsin I is an oligomannose-carrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via glia-derived exosomes. J. Neurosci. 2011;31:7275&#x2013;7290. doi: 10.1523/JNEUROSCI.6476-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6476-10.2011</ArticleId><ArticleId IdType="pmc">PMC6622588</ArticleId><ArticleId IdType="pubmed">21593312</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.C., Liu L., Ma F., Wong C.W., Guo X.E., Chacko J.V., Farhoodi H.P., Zhang S.X., Zimak J., S&#xe9;galiny A. Elucidation of exosome migration across the blood&#x2013;brain barrier model in vitro. Cell. Mol. Bioeng. 2016;9:509&#x2013;529. doi: 10.1007/s12195-016-0458-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12195-016-0458-3</ArticleId><ArticleId IdType="pmc">PMC5382965</ArticleId><ArticleId IdType="pubmed">28392840</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuda T., Oki K., Ochiya T. Stem Cell Renewal and Cell-Cell Communication. Springer; Berlin/Heidelberg, Germany: 2014. Potential application of extracellular vesicles of human adipose tissue-derived mesenchymal stem cells in Alzheimer&#x2019;s disease therapeutics; pp. 171&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">25085563</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui G.H., Wu J., Mou F.F., Xie W.H., Wang F.B., Wang Q.L., Fang J., Xu Y.W., Dong Y.R., Liu J.R. Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice. FASEB J. 2018;32:654&#x2013;668. doi: 10.1096/fj.201700600R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700600R</ArticleId><ArticleId IdType="pubmed">28970251</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.-S., Jia J., Wang Z. Mesenchymal stem cell-derived extracellular vesicles suppresses iNOS expression and ameliorates neural impairment in Alzheimer&#x2019;s disease mice. J. Alzheimer&#x2019;s Dis. 2018;61:1005&#x2013;1013. doi: 10.3233/JAD-170848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170848</ArticleId><ArticleId IdType="pubmed">29254100</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia C.A., Tamborini M., Rasile M., Desiato G., Marchetti S., Swuec P., Mazzitelli S., Clemente F., Anselmo A., Matteoli M. Intracerebral injection of extracellular vesicles from mesenchymal stem cells exerts reduced A&#x3b2; plaque burden in early stages of a preclinical model of Alzheimer&#x2019;s disease. Cells. 2019;8:1059. doi: 10.3390/cells8091059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8091059</ArticleId><ArticleId IdType="pmc">PMC6770482</ArticleId><ArticleId IdType="pubmed">31510042</ArticleId></ArticleIdList></Reference><Reference><Citation>De Godoy M.A., Saraiva L.M., de Carvalho L.R., Vasconcelos-dos-Santos A., Beiral H.J., Ramos A.B., de Paula Silva L.R., Leal R.B., Monteiro V.H., Braga C.V. Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-&#x3b2; oligomers. J. Biol. Chem. 2018;293:1957&#x2013;1975. doi: 10.1074/jbc.M117.807180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.807180</ArticleId><ArticleId IdType="pmc">PMC5808759</ArticleId><ArticleId IdType="pubmed">29284679</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha S., Shen X., Cao Y., Qu L. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer&#x2019;s disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/&#x3b2;-catenin pathway. Aging. 2021;13:15285. doi: 10.18632/aging.203088.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203088</ArticleId><ArticleId IdType="pmc">PMC8221351</ArticleId><ArticleId IdType="pubmed">34086603</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Liu Y., Li J., Wang T., Hei Y., Li H., Wang X., Wang L., Zhao R., Liu W. Tail-vein injection of MSC-derived small extracellular vesicles facilitates the restoration of hippocampal neuronal morphology and function in APP/PS1 mice. Cell Death Discov. 2021;7:230. doi: 10.1038/s41420-021-00620-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00620-y</ArticleId><ArticleId IdType="pmc">PMC8418600</ArticleId><ArticleId IdType="pubmed">34482379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.Y., Kwon S., Um W., Shin S., Kim C.H., Park J.H., Kim B.S. Functional Extracellular Vesicles for Regenerative Medicine. Small. 2022;18:e2106569. doi: 10.1002/smll.202106569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/smll.202106569</ArticleId><ArticleId IdType="pubmed">35322545</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin T., Liu Y., Ji W., Zhuang J., Chen X., Gong B., Chu J., Liang W., Gao J., Yin Y. Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer&#x2019;s disease. Theranostics. 2023;13:1264. doi: 10.7150/thno.81860.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.81860</ArticleId><ArticleId IdType="pmc">PMC10008732</ArticleId><ArticleId IdType="pubmed">36923533</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahangard Y., Monfared H., Moradi A., Zare M., Mirnajafi-Zadeh J., Mowla S.J. Therapeutic Effects of Transplanted Exosomes Containing miR-29b to a Rat Model of Alzheimer&#x2019;s Disease. Front. Neurosci. 2020;14:564. doi: 10.3389/fnins.2020.00564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00564</ArticleId><ArticleId IdType="pmc">PMC7314926</ArticleId><ArticleId IdType="pubmed">32625049</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Jin M., Ji M., Zhang W., Liu A., Wang T. Hypoxic pretreatment of adipose-derived stem cell exosomes improved cognition by delivery of circ-Epc1 and shifting microglial M1/M2 polarization in an Alzheimer&#x2019;s disease mice model. Aging. 2022;14:3070&#x2013;3083. doi: 10.18632/aging.203989.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203989</ArticleId><ArticleId IdType="pmc">PMC9037259</ArticleId><ArticleId IdType="pubmed">35366241</ArticleId></ArticleIdList></Reference><Reference><Citation>Reza-Zaldivar E.E., Hern&#xe1;ndez-Sapi&#xe9;ns M.A., Guti&#xe9;rrez-Mercado Y.K., Sandoval-&#xc1;vila S., Gomez-Pinedo U., M&#xe1;rquez-Aguirre A.L., V&#xe1;zquez-M&#xe9;ndez E., Padilla-Camberos E., Canales-Aguirre A.A. Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer&#x2019;s disease. Neural Regen. Res. 2019;14:1626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6557105</ArticleId><ArticleId IdType="pubmed">31089063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding M., Shen Y., Wang P., Xie Z., Xu S., Zhu Z., Wang Y., Lyu Y., Wang D., Xu L., et al. Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer&#x2019;s Disease. Neurochem. Res. 2018;43:2165&#x2013;2177. doi: 10.1007/s11064-018-2641-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2641-5</ArticleId><ArticleId IdType="pubmed">30259257</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin H., Li Y., Buller B., Katakowski M., Zhang Y., Wang X., Shang X., Zhang Z.G., Chopp M. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells. 2012;30:1556&#x2013;1564. doi: 10.1002/stem.1129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1129</ArticleId><ArticleId IdType="pmc">PMC3495063</ArticleId><ArticleId IdType="pubmed">22605481</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H., Li Y., Ji W., Zhao R., Lu Z., Shen J., Wu Y., Wang J., Hao Q., Wang J., et al. Intranasal Administration of Self-Oriented Nanocarriers Based on Therapeutic Exosomes for Synergistic Treatment of Parkinson&#x2019;s Disease. ACS Nano. 2022;16:869&#x2013;884. doi: 10.1021/acsnano.1c08473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.1c08473</ArticleId><ArticleId IdType="pubmed">34985280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokarizadeh A., Delirezh N., Morshedi A., Mosayebi G., Farshid A.-A., Mardani K. Microvesicles derived from mesenchymal stem cells: Potent organelles for induction of tolerogenic signaling. Immunol. Lett. 2012;147:47&#x2013;54. doi: 10.1016/j.imlet.2012.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2012.06.001</ArticleId><ArticleId IdType="pubmed">22705267</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Liu F., He X., Yang X., Shan F., Feng J. Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Int. Immunopharmacol. 2019;67:268&#x2013;280. doi: 10.1016/j.intimp.2018.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2018.12.001</ArticleId><ArticleId IdType="pubmed">30572251</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark K., Zhang S., Barthe S., Kumar P., Pivetti C., Kreutzberg N., Reed C., Wang Y., Paxton Z., Farmer D., et al. Placental Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Myelin Regeneration in an Animal Model of Multiple Sclerosis. Cells. 2019;8:1497. doi: 10.3390/cells8121497.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8121497</ArticleId><ArticleId IdType="pmc">PMC6952942</ArticleId><ArticleId IdType="pubmed">31771176</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli V., Benedetti E., Antonosante A., Catanesi M., Pitari G., Ippoliti R., Cimini A., d&#x2019;Angelo M. Neuronal cells rearrangement during aging and neurodegenerative disease: Metabolism, oxidative stress and organelles dynamic. Front. Mol. Neurosci. 2019;12:132. doi: 10.3389/fnmol.2019.00132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00132</ArticleId><ArticleId IdType="pmc">PMC6546816</ArticleId><ArticleId IdType="pubmed">31191244</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouli A., Torsney K.M., Kuan W.-L. Parkinson&#x2019;s Disease: Etiology, Neuropathology, and Pathogenesis. Codon Publications; Hong Lim Complex, Singapore: 2018. pp. 3&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">30702842</ArticleId></ArticleIdList></Reference><Reference><Citation>Pringsheim T., Jette N., Frolkis A., Steeves T.D. The prevalence of Parkinson&#x2019;s disease: A systematic review and meta-analysis. Mov. Disord. 2014;29:1583&#x2013;1590. doi: 10.1002/mds.25945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25945</ArticleId><ArticleId IdType="pubmed">24976103</ArticleId></ArticleIdList></Reference><Reference><Citation>Vila&#xe7;a-Faria H., Salgado A.J., Teixeira F.G. Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson&#x2019;s Disease? Cells. 2019;8:118. doi: 10.3390/cells8020118.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8020118</ArticleId><ArticleId IdType="pmc">PMC6406999</ArticleId><ArticleId IdType="pubmed">30717429</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhya R., Shetty A.K. Extracellular Vesicles for the Diagnosis and Treatment of Parkinson&#x2019;s Disease. Aging Dis. 2021;12:1438&#x2013;1450. doi: 10.14336/AD.2021.0516.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.0516</ArticleId><ArticleId IdType="pmc">PMC8407884</ArticleId><ArticleId IdType="pubmed">34527420</ArticleId></ArticleIdList></Reference><Reference><Citation>d&#x2019;Angelo M., Cimini A., Castelli V. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson&#x2019;s Disease. Int. J. Mol. Sci. 2020;21:5241. doi: 10.3390/ijms21155241.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155241</ArticleId><ArticleId IdType="pmc">PMC7432166</ArticleId><ArticleId IdType="pubmed">32718092</ArticleId></ArticleIdList></Reference><Reference><Citation>Heris R.M., Shirvaliloo M., Abbaspour-Aghdam S., Hazrati A., Shariati A., Youshanlouei H.R., Niaragh F.J., Valizadeh H., Ahmadi M. The potential use of mesenchymal stem cells and their exosomes in Parkinson&#x2019;s disease treatment. Stem Cell Res. Ther. 2022;13:371. doi: 10.1186/s13287-022-03050-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-022-03050-4</ArticleId><ArticleId IdType="pmc">PMC9331055</ArticleId><ArticleId IdType="pubmed">35902981</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli V., d&#x2019;Angelo M., Lombardi F., Alfonsetti M., Antonosante A., Catanesi M., Benedetti E., Palumbo P., Cifone M.G., Giordano A. Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson&#x2019;s disease models. Aging. 2020;12:4641. doi: 10.18632/aging.102927.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102927</ArticleId><ArticleId IdType="pmc">PMC7093198</ArticleId><ArticleId IdType="pubmed">32155131</ArticleId></ArticleIdList></Reference><Reference><Citation>Caggiu E., Arru G., Hosseini S., Niegowska M., Sechi G., Zarbo I.R., Sechi L.A. Inflammation, infectious triggers, and Parkinson&#x2019;s disease. Front. Neurol. 2019;10:122. doi: 10.3389/fneur.2019.00122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00122</ArticleId><ArticleId IdType="pmc">PMC6389614</ArticleId><ArticleId IdType="pubmed">30837941</ArticleId></ArticleIdList></Reference><Reference><Citation>Record M., Silvente-Poirot S., Poirot M., Wakelam M.O. Extracellular vesicles: Lipids as key components of their biogenesis and functions. J. Lipid Res. 2018;59:1316&#x2013;1324. doi: 10.1194/jlr.E086173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.E086173</ArticleId><ArticleId IdType="pmc">PMC6071772</ArticleId><ArticleId IdType="pubmed">29764923</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Sun T., An J., Wen L., Liu F., Bu Z., Cui Y., Feng J. Potential roles of exosomes in Parkinson&#x2019;s disease: From pathogenesis, diagnosis, and treatment to prognosis. Front. Cell Dev. Biol. 2020;8:86. doi: 10.3389/fcell.2020.00086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00086</ArticleId><ArticleId IdType="pmc">PMC7047039</ArticleId><ArticleId IdType="pubmed">32154247</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonntag K.-C. MicroRNAs and deregulated gene expression networks in neurodegeneration. Brain Res. 2010;1338:48&#x2013;57. doi: 10.1016/j.brainres.2010.03.106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.03.106</ArticleId><ArticleId IdType="pmc">PMC2883630</ArticleId><ArticleId IdType="pubmed">20380815</ArticleId></ArticleIdList></Reference><Reference><Citation>Elangovan A., Venkatesan D., Selvaraj P., Pasha M.Y., Babu H.W.S., Iyer M., Narayanasamy A., Subramaniam M.D., Valsala Gopalakrishnan A., Kumar N.S. miRNA in Parkinson&#x2019;s disease: From pathogenesis to theranostic approaches. J. Cell. Physiol. 2023;238:329&#x2013;354. doi: 10.1002/jcp.30932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.30932</ArticleId><ArticleId IdType="pubmed">36502506</ArticleId></ArticleIdList></Reference><Reference><Citation>Baglio S.R., Rooijers K., Koppers-Lalic D., Verweij F.J., Lanz&#xf3;n M.P., Zini N., Naaijkens B., Perut F., Niessen H.W., Baldini N. Human bone marrow-and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res. Ther. 2015;6:127. doi: 10.1186/s13287-015-0116-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-015-0116-z</ArticleId><ArticleId IdType="pmc">PMC4529699</ArticleId><ArticleId IdType="pubmed">26129847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.-J., Patel S., Lee S.-J. Intravesicular localization and exocytosis of &#x3b1;-synuclein and its aggregates. J. Neurosci. 2005;25:6016&#x2013;6024. doi: 10.1523/JNEUROSCI.0692-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0692-05.2005</ArticleId><ArticleId IdType="pmc">PMC6724798</ArticleId><ArticleId IdType="pubmed">15976091</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Erviti L., Couch Y., Richardson J., Cooper J.M., Wood M.J. Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line. Neurosci. Res. 2011;69:337&#x2013;342. doi: 10.1016/j.neures.2010.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2010.12.020</ArticleId><ArticleId IdType="pubmed">21255620</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Erviti L., Seow Y., Schapira A.H., Gardiner C., Sargent I.L., Wood M.J., Cooper J.M. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol. Dis. 2011;42:360&#x2013;367. doi: 10.1016/j.nbd.2011.01.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.01.029</ArticleId><ArticleId IdType="pmc">PMC3107939</ArticleId><ArticleId IdType="pubmed">21303699</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Gedalya T., Loeb V., Israeli E., Altschuler Y., Selkoe D.J., Sharon R. &#x3b1;-Synuclein and Polyunsaturated Fatty Acids Promote Clathrin-Mediated Endocytosis and Synaptic Vesicle Recycling. Traffic. 2009;10:218&#x2013;234. doi: 10.1111/j.1600-0854.2008.00853.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2008.00853.x</ArticleId><ArticleId IdType="pmc">PMC2694501</ArticleId><ArticleId IdType="pubmed">18980610</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabin D.E., Shimazu K., Murphy D., Cole N.B., Gottschalk W., McIlwain K.L., Orrison B., Chen A., Ellis C.E., Paylor R. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking &#x3b1;-synuclein. J. Neurosci. 2002;22:8797&#x2013;8807. doi: 10.1523/JNEUROSCI.22-20-08797.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-20-08797.2002</ArticleId><ArticleId IdType="pmc">PMC6757677</ArticleId><ArticleId IdType="pubmed">12388586</ArticleId></ArticleIdList></Reference><Reference><Citation>Danzer K.M., Kranich L.R., Ruf W.P., Cagsal-Getkin O., Winslow A.R., Zhu L., Vanderburg C.R., McLean P.J. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol. Neurodegener. 2012;7:42. doi: 10.1186/1750-1326-7-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-42</ArticleId><ArticleId IdType="pmc">PMC3483256</ArticleId><ArticleId IdType="pubmed">22920859</ArticleId></ArticleIdList></Reference><Reference><Citation>Grey M., Dunning C.J., Gaspar R., Grey C., Brundin P., Sparr E., Linse S. Acceleration of &#x3b1;-synuclein aggregation by exosomes. J. Biol. Chem. 2015;290:2969&#x2013;2982. doi: 10.1074/jbc.M114.585703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.585703</ArticleId><ArticleId IdType="pmc">PMC4317028</ArticleId><ArticleId IdType="pubmed">25425650</ArticleId></ArticleIdList></Reference><Reference><Citation>Vella L.J., Hill A.F., Cheng L. Focus on extracellular vesicles: Exosomes and their role in protein trafficking and biomarker potential in Alzheimer&#x2019;s and Parkinson&#x2019;s disease. Int. J. Mol. Sci. 2016;17:173. doi: 10.3390/ijms17020173.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17020173</ArticleId><ArticleId IdType="pmc">PMC4783907</ArticleId><ArticleId IdType="pubmed">26861304</ArticleId></ArticleIdList></Reference><Reference><Citation>Postuma R.B., Berg D., Stern M., Poewe W., Olanow C.W., Oertel W., Obeso J., Marek K., Litvan I., Lang A.E. MDS clinical diagnostic criteria for Parkinson&#x2019;s disease. Mov. Disord. 2015;30:1591&#x2013;1601. doi: 10.1002/mds.26424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26424</ArticleId><ArticleId IdType="pubmed">26474316</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri K.R., Healy D.G., Schapira A.H. Non-motor symptoms of Parkinson&#x2019;s disease: Diagnosis and management. Lancet Neurol. 2006;5:235&#x2013;245. doi: 10.1016/S1474-4422(06)70373-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(06)70373-8</ArticleId><ArticleId IdType="pubmed">16488379</ArticleId></ArticleIdList></Reference><Reference><Citation>Canesi M., Giordano R., Lazzari L., Isalberti M., Isaias I.U., Benti R., Rampini P., Marotta G., Colombo A., Cereda E., et al. Finding a new therapeutic approach for no-option Parkinsonisms: Mesenchymal stromal cells for progressive supranuclear palsy. J. Transl. Med. 2016;14:127. doi: 10.1186/s12967-016-0880-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-016-0880-2</ArticleId><ArticleId IdType="pmc">PMC4862050</ArticleId><ArticleId IdType="pubmed">27160012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocansey D.K.W., Pei B., Yan Y., Qian H., Zhang X., Xu W., Mao F. Improved therapeutics of modified mesenchymal stem cells: An update. J. Transl. Med. 2020;18:42. doi: 10.1186/s12967-020-02234-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02234-x</ArticleId><ArticleId IdType="pmc">PMC6993499</ArticleId><ArticleId IdType="pubmed">32000804</ArticleId></ArticleIdList></Reference><Reference><Citation>Fri&#x10d;ov&#xe1; D., Korchak J.A., Zubair A.C. Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson&#x2019;s disease. NPJ Regen. Med. 2020;5:20. doi: 10.1038/s41536-020-00106-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41536-020-00106-y</ArticleId><ArticleId IdType="pmc">PMC7641157</ArticleId><ArticleId IdType="pubmed">33298940</ArticleId></ArticleIdList></Reference><Reference><Citation>Haney M.J., Klyachko N.L., Zhao Y., Gupta R., Plotnikova E.G., He Z., Patel T., Piroyan A., Sokolsky M., Kabanov A.V., et al. Exosomes as drug delivery vehicles for Parkinson&#x2019;s disease therapy. J. Control. Release Off. J. Control. Release Soc. 2015;207:18&#x2013;30. doi: 10.1016/j.jconrel.2015.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2015.03.033</ArticleId><ArticleId IdType="pmc">PMC4430381</ArticleId><ArticleId IdType="pubmed">25836593</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu M., Lin Q., Huang L., Fu Y., Wang L., He S., Fu Y., Yang S., Zhang Z., Zhang L., et al. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson&#x2019;s disease. J. Control. Release Off. J. Control. Release Soc. 2018;287:156&#x2013;166. doi: 10.1016/j.jconrel.2018.08.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2018.08.035</ArticleId><ArticleId IdType="pubmed">30165139</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta R., Trapp B.D. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog. Neurobiol. 2011;93:1&#x2013;12. doi: 10.1016/j.pneurobio.2010.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2010.09.005</ArticleId><ArticleId IdType="pmc">PMC3030928</ArticleId><ArticleId IdType="pubmed">20946934</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapp B.D., B&#xf6; L., M&#xf6;rk S., Chang A. Pathogenesis of tissue injury in MS lesions. J. Neuroimmunol. 1999;98:49&#x2013;56. doi: 10.1016/S0165-5728(99)00081-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(99)00081-8</ArticleId><ArticleId IdType="pubmed">10426362</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis S., Sonnberger M., Dunzinger A., Voglmayr E., Aichholzer M., Kleiser R., Strasser P. Imaging Brain Diseases. Springer; Berlin/Heidelberg, Germany: 2019. Demyelinating Diseases: Multiple Sclerosis; pp. 1071&#x2013;1095.</Citation></Reference><Reference><Citation>Lopez-Diego R.S., Weiner H.L. Novel therapeutic strategies for multiple sclerosis&#x2014;A multifaceted adversary. Nat. Rev. Drug Discov. 2008;7:909&#x2013;925. doi: 10.1038/nrd2358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd2358</ArticleId><ArticleId IdType="pubmed">18974749</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalu M.M., Sullivan K.J., Mei S.H., Moher D., Straus A., Fergusson D.A., Stewart D.J., Jazi M., MacLeod M., Winston B. Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial. Elife. 2016;5:e17850. doi: 10.7554/eLife.17850.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.17850</ArticleId><ArticleId IdType="pmc">PMC5153252</ArticleId><ArticleId IdType="pubmed">27870924</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan T.S., Giacoppo S., Diomede F., Ballerini P., Paolantonio M., Marchisio M., Piattelli A., Bramanti P., Mazzon E., Trubiani O. The secretome of periodontal ligament stem cells from MS patients protects against EAE. Sci. Rep. 2016;6:38743. doi: 10.1038/srep38743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep38743</ArticleId><ArticleId IdType="pmc">PMC5141419</ArticleId><ArticleId IdType="pubmed">27924938</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarinia M., Alsahebfosoul F., Salehi H., Eskandari N., Azimzadeh M., Mahmoodi M., Asgary S., Ganjalikhani Hakemi M. Therapeutic effects of extracellular vesicles from human adipose-derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis. J. Cell. Physiol. 2020;235:8779&#x2013;8790. doi: 10.1002/jcp.29721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.29721</ArticleId><ArticleId IdType="pubmed">32329062</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz S., Bozorgmehr N., Koleva P., Namdar A., Jovel J., Fava R.A., Elahi S. CD71+ VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-&#x3b2;. PLoS Biol. 2018;16:e2006649. doi: 10.1371/journal.pbio.2006649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2006649</ArticleId><ArticleId IdType="pmc">PMC6310287</ArticleId><ArticleId IdType="pubmed">30550561</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu F., Shi M., Zheng C., Shen D., Zhu J., Zheng X., Cui L. The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2018;318:1&#x2013;7. doi: 10.1016/j.jneuroim.2018.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2018.02.015</ArticleId><ArticleId IdType="pubmed">29606295</ArticleId></ArticleIdList></Reference><Reference><Citation>Song G.J., Suk K. Pharmacological modulation of functional phenotypes of microglia in neurodegenerative diseases. Front. Aging Neurosci. 2017;9:139. doi: 10.3389/fnagi.2017.00139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00139</ArticleId><ArticleId IdType="pmc">PMC5430023</ArticleId><ArticleId IdType="pubmed">28555105</ArticleId></ArticleIdList></Reference><Reference><Citation>Farinazzo A., Angiari S., Turano E., Bistaffa E., Dusi S., Ruggieri S., Bonafede R., Mariotti R., Constantin G., Bonetti B. Nanovesicles from adipose-derived mesenchymal stem cells inhibit T lymphocyte trafficking and ameliorate chronic experimental autoimmune encephalomyelitis. Sci. Rep. 2018;8:7473. doi: 10.1038/s41598-018-25676-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25676-2</ArticleId><ArticleId IdType="pmc">PMC5945853</ArticleId><ArticleId IdType="pubmed">29748664</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Fern&#xe1;ndez M., de la Cuesta F., Tall&#xf3;n A., Cuesta I., Fern&#xe1;ndez-Fournier M., Laso-Garc&#xed;a F., G&#xf3;mez-de Frutos M.C., D&#xed;ez-Tejedor E., Otero-Ortega L. Potential Roles of Extracellular Vesicles as Biomarkers and a Novel Treatment Approach in Multiple Sclerosis. Int. J. Mol. Sci. 2021;22:9011. doi: 10.3390/ijms22169011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22169011</ArticleId><ArticleId IdType="pmc">PMC8396540</ArticleId><ArticleId IdType="pubmed">34445717</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayazi N., Sheykhhasan M., Asl S.S., Najafi R. Stem Cell-Derived Exosomes: A New Strategy of Neurodegenerative Disease Treatment. Mol. Neurobiol. 2021;58:3494&#x2013;3514. doi: 10.1007/s12035-021-02324-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02324-x</ArticleId><ArticleId IdType="pmc">PMC7981389</ArticleId><ArticleId IdType="pubmed">33745116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadzadeh A., Pourfathollah A.A., Shahrokhi S., Fallah A., Tahoori M.T., Amari A., Forouzandeh M., Soleimani M. Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-&#x3b2; delivery in experimental autoimmune encephalomyelitis. Clin. Immunol. 2016;169:98&#x2013;106. doi: 10.1016/j.clim.2016.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.06.015</ArticleId><ArticleId IdType="pubmed">27373971</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W., Pham V., Liu L., Riazifar M., Pone E.J., Zhang S.X., Ma F., Lu M., Walsh C.M., Zhao W. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis. Biomaterials. 2016;77:87&#x2013;97. doi: 10.1016/j.biomaterials.2015.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2015.11.005</ArticleId><ArticleId IdType="pmc">PMC4684451</ArticleId><ArticleId IdType="pubmed">26584349</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott E.O., Malek A.M., Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handb. Clin. Neurol. 2016;138:225&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>Comley L., Allodi I., Nichterwitz S., Nizzardo M., Simone C., Corti S., Hedlund E. Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS. Neuroscience. 2015;291:216&#x2013;229. doi: 10.1016/j.neuroscience.2015.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.02.013</ArticleId><ArticleId IdType="pubmed">25697826</ArticleId></ArticleIdList></Reference><Reference><Citation>Farinazzo A., Turano E., Marconi S., Bistaffa E., Bazzoli E., Bonetti B. Murine adipose-derived mesenchymal stromal cell vesicles: In vitro clues for neuroprotective and neuroregenerative approaches. Cytotherapy. 2015;17:571&#x2013;578. doi: 10.1016/j.jcyt.2015.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2015.01.005</ArticleId><ArticleId IdType="pubmed">25743633</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin H., Li Y., Liu Z., Wang X., Shang X., Cui Y., Zhang Z.G., Chopp M. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 2013;31:2737&#x2013;2746. doi: 10.1002/stem.1409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1409</ArticleId><ArticleId IdType="pmc">PMC3788061</ArticleId><ArticleId IdType="pubmed">23630198</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M., Ban J.-J., Kim K.Y., Jeon G.S., Im W., Sung J.-J., Kim M. Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro. Biochem. Biophys. Res. Commun. 2016;479:434&#x2013;439. doi: 10.1016/j.bbrc.2016.09.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.09.069</ArticleId><ArticleId IdType="pubmed">27641665</ArticleId></ArticleIdList></Reference><Reference><Citation>McCluskey G., Morrison K.E., Donaghy C., Rene F., Duddy W., Duguez S. Extracellular Vesicles in Amyotrophic Lateral Sclerosis. Life. 2023;13:121. doi: 10.3390/life13010121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13010121</ArticleId><ArticleId IdType="pmc">PMC9867379</ArticleId><ArticleId IdType="pubmed">36676070</ArticleId></ArticleIdList></Reference><Reference><Citation>Parfejevs V., Sagini K., Buss A., Sobolevska K., Llorente A., Riekstina U., Abols A. Adult Stem Cell-Derived Extracellular Vesicles in Cancer Treatment: Opportunities and Challenges. Cells. 2020;9:1171. doi: 10.3390/cells9051171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9051171</ArticleId><ArticleId IdType="pmc">PMC7290929</ArticleId><ArticleId IdType="pubmed">32397238</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Li Y., Ren C., Wang Y., He W., Jiang Y. Extracellular Vesicles as Innovative Treatment Strategy for Amyotrophic Lateral Sclerosis. Front. Cell Dev. Biol. 2021;9:754630. doi: 10.3389/fcell.2021.754630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.754630</ArticleId><ArticleId IdType="pmc">PMC8632491</ArticleId><ArticleId IdType="pubmed">34858980</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte J., Littleton J.T. The biological function of the Huntingtin protein and its relevance to Huntington&#x2019;s Disease pathology. Curr. Trends Neurol. 2011;5:65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3237673</ArticleId><ArticleId IdType="pubmed">22180703</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron N.S., Dorsey E.R., Hayden M.R. Therapeutic approaches to Huntington disease: From the bench to the clinic. Nat. Rev. Drug Discov. 2018;17:729&#x2013;750. doi: 10.1038/nrd.2018.133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2018.133</ArticleId><ArticleId IdType="pubmed">30237454</ArticleId></ArticleIdList></Reference><Reference><Citation>Croese T., Furlan R. Extracellular vesicles in neurodegenerative diseases. Mol. Asp. Med. 2018;60:52&#x2013;61. doi: 10.1016/j.mam.2017.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2017.11.006</ArticleId><ArticleId IdType="pubmed">29137922</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M., Liu T., Im W., Kim M. Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington&#x2019;s disease in vitro model. Eur. J. Neurosci. 2016;44:2114&#x2013;2119. doi: 10.1111/ejn.13275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13275</ArticleId><ArticleId IdType="pubmed">27177616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.-T., Im W., Ban J.-J., Lee M., Jung K.-H., Lee S.K., Chu K., Kim M. Exosome-based delivery of miR-124 in a Huntington&#x2019;s disease model. J. Mov. Disord. 2017;10:45. doi: 10.14802/jmd.16054.</Citation><ArticleIdList><ArticleId IdType="doi">10.14802/jmd.16054</ArticleId><ArticleId IdType="pmc">PMC5288667</ArticleId><ArticleId IdType="pubmed">28122430</ArticleId></ArticleIdList></Reference><Reference><Citation>Yari H., Mikhailova M.V., Mardasi M., Jafarzadehgharehziaaddin M., Shahrokh S., Thangavelu L., Ahmadi H., Shomali N., Yaghoubi Y., Zamani M., et al. Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: A groundbreaking cell-free approach. Stem Cell Res. Ther. 2022;13:423. doi: 10.1186/s13287-022-03122-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-022-03122-5</ArticleId><ArticleId IdType="pmc">PMC9389725</ArticleId><ArticleId IdType="pubmed">35986375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi M.J., Aliaghaei A., Boroujeni M.E., Khodagholi F., Meftahi G., Abdollahifar M.A., Ahmadi H., Danyali S., Daftari M., Sadeghi Y. Human Umbilical Cord Matrix Stem Cells Reverse Oxidative Stress-Induced Cell Death and Ameliorate Motor Function and Striatal Atrophy in Rat Model of Huntington Disease. Neurotox. Res. 2018;34:273&#x2013;284. doi: 10.1007/s12640-018-9884-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-018-9884-4</ArticleId><ArticleId IdType="pubmed">29520722</ArticleId></ArticleIdList></Reference><Reference><Citation>Didiot M.C., Hall L.M., Coles A.H., Haraszti R.A., Godinho B.M., Chase K., Sapp E., Ly S., Alterman J.F., Hassler M.R., et al. Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing. Mol. Ther. J. Am. Soc. Gene Ther. 2016;24:1836&#x2013;1847. doi: 10.1038/mt.2016.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2016.126</ArticleId><ArticleId IdType="pmc">PMC5112038</ArticleId><ArticleId IdType="pubmed">27506293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy T.L., Russell A.J., Riley P. Experimental limitations of extracellular vesicle-based therapies for the treatment of myocardial infarction. Trends Cardiovasc. Med. 2021;31:405&#x2013;415. doi: 10.1016/j.tcm.2020.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.08.003</ArticleId><ArticleId IdType="pmc">PMC8501308</ArticleId><ArticleId IdType="pubmed">32822840</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzini S. Establishing a working range for effective MSC-EV dose.  [(accessed on 30 June 2023)];RoosterBio. Blog. 2021  Available online:  https://www.roosterbio.com/blog/establishing-a-working-range-for-effective-msc-ev-dose/</Citation></Reference><Reference><Citation>Sun Z., Hou X., Zhang J., Li J., Wu P., Yan L., Qian H. Diagnostic and Therapeutic Roles of Extracellular Vesicles in Aging-Related Diseases. Oxidative Med. Cell. Longev. 2022;2022:6742792. doi: 10.1155/2022/6742792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/6742792</ArticleId><ArticleId IdType="pmc">PMC9377967</ArticleId><ArticleId IdType="pubmed">35979398</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian C.-m., Yang M.-f., Xu H.-m., Zhu M.-z., Zhang Y., Yao J., Wang L.-s., Liang Y.-j., Li D.-f. Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases. Stem Cells Int. 2023;2023:4245704. doi: 10.1155/2023/4245704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/4245704</ArticleId><ArticleId IdType="pmc">PMC10089786</ArticleId><ArticleId IdType="pubmed">37056457</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann I.K., Wood M.J.A., Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat. Nanotechnol. 2021;16:748&#x2013;759. doi: 10.1038/s41565-021-00931-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41565-021-00931-2</ArticleId><ArticleId IdType="pubmed">34211166</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Zhang T., Gao J. Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment. BioDrugs. 2022;36:701&#x2013;715. doi: 10.1007/s40259-022-00555-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40259-022-00555-5</ArticleId><ArticleId IdType="pmc">PMC9463673</ArticleId><ArticleId IdType="pubmed">36087245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>